BEUDAMED
    FDA Adverse Event Injury Summary report: N

    SMARTPILL

    MDR report key: 16054100 · Received December 27, 2022

    Report

    Report Number
    9710107-2022-00263
    Event Type
    Injury
    Date Received
    December 27, 2022
    Date of Event
    October 17, 2022
    Report Date
    December 27, 2022
    Manufacturer
    GIVEN IMAGING LTD., YOQNEAM
    Product Code
    NYV
    PMA / PMN Number
    K092342
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    GA, US
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    EVALUATION SUMMARY: MEDTRONIC CONDUCTED AN INVESTIGATION BASED UPON ALL INFORMATION RECEIVED. THE INVOLVED DEVICE WAS NOT RETURNED. NO INFORMATION REGARDING THE SPECIFIC CUSTOMER ISSUE THAT OCCURRED WITH THE DEVICE WAS AVAILABLE. IT WAS REPORTED THAT THE CAPSULE REMAINED IN THE PATIENT LONGER THAN EXPECTED. THE REPORTED ISSUE WAS CONFIRMED. THE MOST LIKELY CAUSE COULD NOT BE ESTABLISHED FROM THE INFORMATION AVAILABLE. THE MANUFACTURING RECORDS FOR EACH DEVICE ARE THOROUGHLY REVIEWED PRIOR TO RELEASE TO ENSURE THAT IT MEETS ALL MEDTRONIC QUALITY SPECIFICATIONS. A SECONDARY REVIEW OF THE DEVICE HISTORY RECORDS FOUND NO POTENTIALLY CONTRIBUTING FACTORS. THE INSTRUCTIONS INCLUDED WITH THIS DEVICE PROVIDE THE FOLLOWING GUIDANCE: RISKS ASSOCIATED WITH CAPSULE INGESTION AND TRANSIT IS MINIMAL. THE PRIMARY HAZARD IS CAPSULE RETENTION. RETENTION INCIDENCE, AS DETERMINED BY A REVIEW OF PUBLISHED STUDIES OF CAPSULE ENDOSCOPY IN ADULTS, IS ESTIMATED AS 0.75% IN PATIENTS WITHOUT KNOWN STENOSIS AND 21% IN PATIENTS WITH KNOWN STENOSIS. STENOSIS AND STRICTURES CAN BE COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE. (DOC-4092-01). MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Description of Event or Problem · 0

    ACCORDING TO THE REPORTER, THE STUDY DID NOT LOOK RIGHT. THE CAPSULE STAYED IN PATIENT STOMACH. PATIENT CONTACTED THE MEDICAL DOCTOR'S OFFICE WITH COMPLAINTS OF ABDOMINAL PAIN. DOCTOR BROUGHT PATIENT IN FOR AN UPPER ENDOSCOPY AND FOUND THE CAPSULE WAS LODGED IN THE PYLORUS FROM AN AREA OF STENOSIS AND THE CAPSULE NEVER PASSED OUT OF THIS AREA. THE CAPSULE WAS ABLE TO RETRIEVE USING A RETRIEVAL NET AND THE PATIENT HAD A SMALL ULCER FROM THE CAPSULE BEING LODGED. THE PATIENT WAS FINE AND STABLE AFTER THE PROCEDURE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2726633 SMARTPILL GASTROINTESTINAL MOTILITY SYSTEM, CAPSULE NYV GIVEN IMAGING LTD., YOQNEAM FGS-0503 57327P

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Required Intervention